In this episode, Jill Blumenthal, MD, MAS, discusses HIV pre-exposure prophylaxis (PrEP) considerations for transgender and nonbinary individuals, including:
- Providing gender-affirming care
- Integrating PrEP and gender care
- Taking a sexual history and addressing sexual health
- PrEP efficacy and options for transgender individuals, including FTC/TDF, FTC/TAF, and long-acting CAB
- The importance of reassuring transgender individuals that data suggest there are no drug–drug interactions between gender-affirming hormone therapy and any of the PrEP options
Jill Blumenthal, MD, MAS (she/hers)Associate Professor of MedicineInfectious Diseases and Global Public HealthUniversity of California, San DiegoSan Diego, California
See the full program at: https://bit.ly/3WhbBvZ